Leiden Academic Centre for Drug Research
The Leiden Academic Centre for Drug Research (LACDR) is a centre of excellence for multidisciplinary research on drug discovery and development.
Despite major advances in medicine- research, many common diseases such as cancers, neurological or cardiovascular diseases, or auto-immune diseases, still lack effective treatment, or are still often found incurable.
That is why our work to develop new and more effective drugs is essential. At the LACDR we work at the leading edge of drug-design and fundamental research of new drugs, optimization of existing drugs, and personalised medicine.
Education in Biopharmaceutical Sciences
Our education ranges the Bachelor's and Master's programs in Bio-Pharmaceutical Sciences, Pharmacy and the LACDR PhD programme. We are committed to providing quality graduate experiences in a personalized environment of cutting edge research and internationally renowned supervisors.
Research
Our research is focused in four divisions and one research centre: Cell Systems and Drug Safety, BioTherapeutics, Medicinal Chemistry, Systems Pharmacology and Pharmacy, and the Metabolomics and Analytics Centre, which you can find below:
News
Events
-
Gut Microbial Metabolomics to Understand Allergies in Early Life
-
LED3 Lecture: The discovery and mechanism of lipid transport inhibition by the antibiotic Zosurabalpin
-
From labelled to the optimal clinical dose: Model-informed dose optimization in medical oncology practice
-
Modeling and Targeting Tissue Dynamics in Fibrosis and Cancer
Education
Study Association
